You are here

Antipsychotic drugs for dementia 'linked to diabetic hyperglycaemia'

Antipsychotic drugs for dementia 'linked to diabetic hyperglycaemia'
31st July 2009

A range of antipsychotic drugs used to combat dementia symptoms and other mental issues with older people may turn out to be dangerous for those with diabetes, according to a new study.

Publishing their results in the Archives of Internal Medicine, representatives from the Institute for Clinical Evaluative Sciences and the Women’s College Research Institute at Women’s College Hospital from Toronto, Canada, it was said that hyperglycaemia was very possible in such individuals.

The drugs are already known to carry a number of risks including an increased risk of stroke, diabetes and Parkinson's disease.

Commenting on the results, authors wrote: "The new use of both atypical and typical antipsychotic drugs was associated with a significant increase in hospitalisations for hyperglycemia, which appeared independent of baseline diabetes treatment and was strikingly high during the initial period of antipsychotic therapy."

Earlier this month, the government was criticised for its lack of commitment to treating dementia by Rebecca Wood, the chief executive of the Alzheimer's Research Trust.

Please click here for advice to help you find the right type of care.